XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF BENEFICIARIES’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Rabbi Trust/Deferred Compensation Shares
Additional Paid-in Capital
Common Shares in Grantor Trust
Cumulative Earnings
Accumulated Other Comprehensive Income (Loss)
Cumulative Distributions
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021   171,126,257 1,169,703            
Beginning balance at Dec. 31, 2021 $ 1,701,219 $ 1,712 $ 18,491 $ 3,146,786 $ (18,491) $ 1,122,372 $ (2,020) $ (2,578,583) $ 10,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 6,101         6,093     8
Other comprehensive income (loss) 3,952           3,940   12
Redemption of LP Units (4,006)               (4,006)
Share-based compensation activity (in shares)   277,061 68,540            
Share-based compensation activity 1,655 $ 2   1,653          
Share Issuance from/(to) Deferred Compensation Plan (in shares)   (19,406) (52,702)            
Share Issuance from/(to) Deferred Compensation Plan (249)   $ 895 (249) (895)        
Reallocation of Noncontrolling interest 0     (959)         959
Distributions declared (32,809)             (32,711) (98)
Ending balance (in shares) at Mar. 31, 2022   171,383,912 1,185,541            
Ending balance at Mar. 31, 2022 1,675,863 $ 1,714 $ 19,386 3,147,231 (19,386) 1,128,465 1,920 (2,611,294) 7,827
Beginning balance (in shares) at Dec. 31, 2021   171,126,257 1,169,703            
Beginning balance at Dec. 31, 2021 1,701,219 $ 1,712 $ 18,491 3,146,786 (18,491) 1,122,372 (2,020) (2,578,583) 10,952
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 10,752                
Other comprehensive income (loss) 5,887                
Ending balance (in shares) at Jun. 30, 2022   171,575,280 1,202,385            
Ending balance at Jun. 30, 2022 1,651,563 $ 1,716 $ 19,601 3,149,146 (19,601) 1,133,102 3,849 (2,643,999) 7,749
Beginning balance (in shares) at Mar. 31, 2022   171,383,912 1,185,541            
Beginning balance at Mar. 31, 2022 1,675,863 $ 1,714 $ 19,386 3,147,231 (19,386) 1,128,465 1,920 (2,611,294) 7,827
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 4,651         4,637     14
Other comprehensive income (loss) 1,935           1,929   6
Share-based compensation activity (in shares)   191,368 16,844            
Share-based compensation activity 1,917 $ 2   1,915          
Share Issuance from/(to) Deferred Compensation Plan 0   $ 215   (215)        
Distributions declared (32,803)             (32,705) (98)
Ending balance (in shares) at Jun. 30, 2022   171,575,280 1,202,385            
Ending balance at Jun. 30, 2022 $ 1,651,563 $ 1,716 $ 19,601 3,149,146 (19,601) 1,133,102 3,849 (2,643,999) 7,749
Beginning balance (in shares) at Dec. 31, 2022 171,569,807 171,569,807 1,179,643            
Beginning balance at Dec. 31, 2022 $ 1,633,334 $ 1,716 $ 19,601 3,153,229 (19,601) 1,176,195 3,897 (2,709,405) 7,702
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (5,276)         (5,259)     (17)
Other comprehensive income (loss) (5,291)           (5,307)   16
Share-based compensation activity (in shares)   171,318 22,449            
Share-based compensation activity 3,371 $ 1   3,370          
Share Issuance from/(to) Deferred Compensation Plan (in shares)   (13,422) (48,733)            
Share Issuance from/(to) Deferred Compensation Plan (88)   $ 145 (88) (145)        
Reallocation of Noncontrolling interest 0     (4)         4
Distributions declared (32,832)             (32,734) (98)
Ending balance (in shares) at Mar. 31, 2023   171,727,703 1,153,359            
Ending balance at Mar. 31, 2023 $ 1,593,218 $ 1,717 $ 19,746 3,156,507 (19,746) 1,170,936 (1,410) (2,742,139) 7,607
Beginning balance (in shares) at Dec. 31, 2022 171,569,807 171,569,807 1,179,643            
Beginning balance at Dec. 31, 2022 $ 1,633,334 $ 1,716 $ 19,601 3,153,229 (19,601) 1,176,195 3,897 (2,709,405) 7,702
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (18,013)                
Other comprehensive income (loss) $ 1,355                
Ending balance (in shares) at Jun. 30, 2023 172,101,929 172,101,929 1,207,415            
Ending balance at Jun. 30, 2023 $ 1,556,660 $ 1,719 $ 19,965 3,159,276 (19,965) 1,158,240 5,216 (2,775,124) 7,333
Beginning balance (in shares) at Mar. 31, 2023   171,727,703 1,153,359            
Beginning balance at Mar. 31, 2023 1,593,218 $ 1,717 $ 19,746 3,156,507 (19,746) 1,170,936 (1,410) (2,742,139) 7,607
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (12,737)         (12,696)     (41)
Other comprehensive income (loss) 6,646           6,626   20
Share-based compensation activity (in shares)   374,226 54,056            
Share-based compensation activity 2,616 $ 2   2,614          
Share Issuance from/(to) Deferred Compensation Plan 0   $ 219   (219)        
Reallocation of Noncontrolling interest 0     155         (155)
Distributions declared $ (33,083)             (32,985) (98)
Ending balance (in shares) at Jun. 30, 2023 172,101,929 172,101,929 1,207,415            
Ending balance at Jun. 30, 2023 $ 1,556,660 $ 1,719 $ 19,965 $ 3,159,276 $ (19,965) $ 1,158,240 $ 5,216 $ (2,775,124) $ 7,333